. Author manuscript; available in PMC: 2011 Dec 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Dec 1;55(4):510–515. doi: 10.1097/QAI.0b013e3181f53783

Table 3.

Hazard ratios (95% CI) for mortality among those who were HIV-infected compared to those who were HIV-uninfected among 29 lung cancer cases in the ALIVE study, followed between 1988 and 2006

	All Lung Cancer Cases (n=29)			Distant Stage Lung Cancer Cases (n=17)
	Deaths	Age-adjusted HR (95% CI)	Adjusted HR (95% CI)^*	Deaths	Age-adjusted HR (95% CI)	Adjusted HR (95% CI)^†
HIV−	14	1	1	7	1	1
HIV+	12	2.9 (1.0, 8.2)	3.8 (0.92, 15)	9	3.5 (0.85, 15)	4.3 (0.84,22)

ALIVE: AIDS Link to Intravenous Experience; HR: hazard ratio; CI: confidence intervals; IQR: interquartile range

adjusted for age, gender, distant stage, average packs smoked per day, current injection drug use at diagnosis and insurance status at diagnosis

^†

adjusted for age, gender, average packs smoked per day, current injection drug use at diagnosis and insurance status at diagnosis